Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Preben Kjolhede, MD, professor
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Females ages 18 or older with a pelvic or abdominal tumor suspected or histopathologically proven ovarian cancer FIGO stage II-IV who are undergoing primary surgery with the intention of performing optimal cytoreductive radical surgery.
Understand and speak Swedish
Accept participation in the study after written and verbal information and sign informed consent.
You may not be if
Allergy to tranexamic acid
Having had tranexamic acid within the recent 30 days
Previous or present episode of thromboembolic events .
Previous or present treatment within the recent 3 months with anticoagulant.
Previous or present known coagulopathy
Myocardial infarction within the previous 12 months or instable angina pectoris which, according to the investigator, may increase the risk for complications significantly in case of a lowering of the hemoglobin.
Significant renal failure with serum-creatinine \> 250 µmol/l.
Severe psychiatric dysfunction or mentally substantially disabled.
Clareo Health | Tranexamic Acid in Surgery of Advanced Ovarian Cancer
